Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

90 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
2 Adrenergic signaling in cardiomyocytes 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
3 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
4 Alcoholism 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
5 Alcoholism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
6 Alcoholism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
7 Alcoholism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
8 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
9 Alzheimer disease 💬
3件: CHRM1, CHRM3, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
10 Alzheimer disease 💬
3件: CHRM1, CHRM3, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
11 Alzheimer disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
12 Alzheimer disease 💬
1件: MAPT 💬 D11293 💬 Gosuranemab 1件:  5  💬
13 Alzheimer disease 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
14 Alzheimer disease 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
15 Amphetamine addiction 💬
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
16 Amphetamine addiction 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
17 Amphetamine addiction 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
18 Amphetamine addiction 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
19 AMPK signaling pathway 💬
1件: ADRA1A 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
20 Amyotrophic lateral sclerosis 💬
7件: GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
21 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
22 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
23 Arginine and proline metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
24 Arginine and proline metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
25 Arginine and proline metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
26 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
27 Breast cancer 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
28 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
29 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
30 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
31 Calcium signaling pathway 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
32 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
33 Calcium signaling pathway 💬
4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
34 Calcium signaling pathway 💬
4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
35 Calcium signaling pathway 💬
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
36 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
37 cAMP signaling pathway 💬
2件: CHRM1, CHRM2 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
38 cAMP signaling pathway 💬
2件: CHRM1, CHRM2 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
39 cAMP signaling pathway 💬
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
40 Central carbon metabolism in cancer 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
41 cGMP-PKG signaling pathway 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
42 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
43 Chemical carcinogenesis 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
44 Cholinergic synapse 💬
1件: ACHE 💬 D00670 💬 Donepezil 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
45 Cholinergic synapse 💬
1件: ACHE 💬 D07869 💬 Donepezil 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
46 Cholinergic synapse 💬
1件: ACHE 💬 D02558 💬 Rivastigmine 3件:  5 ,  6 , 13 💬
47 Cholinergic synapse 💬
1件: ACHE 💬 D03822 💬 Rivastigmine 3件:  5 ,  6 , 13 💬
48 Cholinergic synapse 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
49 Cholinergic synapse 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
50 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
51 Circadian entrainment 💬
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
52 Cocaine addiction 💬
6件: GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
53 Cocaine addiction 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
54 Cocaine addiction 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
55 Cocaine addiction 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
56 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
57 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
58 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
59 Dopaminergic synapse 💬
6件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
60 Dopaminergic synapse 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
61 Dopaminergic synapse 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
62 Dopaminergic synapse 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
63 Drug metabolism - cytochrome P450 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
64 Drug metabolism - cytochrome P450 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
65 Drug metabolism - cytochrome P450 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
66 GABAergic synapse 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
67 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
68 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
69 Gap junction 💬
1件: ADRB1 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
70 Gastric acid secretion 💬
1件: CHRM3 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
71 Gastric acid secretion 💬
1件: CHRM3 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
72 Glutamatergic synapse 💬
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
73 Glycerophospholipid metabolism 💬
1件: ACHE 💬 D00670 💬 Donepezil 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
74 Glycerophospholipid metabolism 💬
1件: ACHE 💬 D07869 💬 Donepezil 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
75 Glycerophospholipid metabolism 💬
1件: ACHE 💬 D02558 💬 Rivastigmine 3件:  5 ,  6 , 13 💬
76 Glycerophospholipid metabolism 💬
1件: ACHE 💬 D03822 💬 Rivastigmine 3件:  5 ,  6 , 13 💬
77 Glycine, serine and threonine metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
78 Glycine, serine and threonine metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
79 Glycine, serine and threonine metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
80 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
81 Hematopoietic cell lineage 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
82 Histidine metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
83 Histidine metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
84 Histidine metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
85 Human cytomegalovirus infection 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
86 Human cytomegalovirus infection 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
87 Human papillomavirus infection 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
88 Human papillomavirus infection 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
89 Huntington disease 💬
6件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2B 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
90 IL-17 signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
91 IL-17 signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
92 Insulin secretion 💬
1件: CHRM3 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
93 Insulin secretion 💬
1件: CHRM3 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
94 Insulin secretion 💬
1件: SNAP25 💬 D00783 💬 Botulinum toxin type A 13件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
95 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
96 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
97 Leishmaniasis 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
98 Leishmaniasis 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
99 Long-term depression 💬
3件: GRIA1, GRIA2, GRIA3 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
100 Long-term potentiation 💬
7件: GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
101 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
102 MAPK signaling pathway 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
103 MAPK signaling pathway 💬
1件: MAPT 💬 D11293 💬 Gosuranemab 1件:  5  💬
104 Melanogenesis 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
105 Metabolic pathways 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
106 Metabolic pathways 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
107 Metabolic pathways 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
108 Metabolic pathways 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
109 Metabolic pathways 💬
2件: PTGS1, PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
110 Metabolic pathways 💬
2件: PTGS1, PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
111 MicroRNAs in cancer 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
112 MicroRNAs in cancer 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
113 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
114 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
115 Neuroactive ligand-receptor interaction 💬
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
116 Neuroactive ligand-receptor interaction 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
117 Neuroactive ligand-receptor interaction 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
118 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
119 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
120 Neuroactive ligand-receptor interaction 💬
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
121 Neuroactive ligand-receptor interaction 💬
2件: HCRTR1, HCRTR2 💬 D10082 💬 Suvorexant 3件:  5 ,  6 , 13 💬
122 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
123 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
124 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
125 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
126 Nicotine addiction 💬
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
127 Ovarian steroidogenesis 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
128 Ovarian steroidogenesis 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
129 Oxytocin signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
130 Oxytocin signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
131 Pancreatic secretion 💬
1件: CHRM3 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
132 Pancreatic secretion 💬
1件: CHRM3 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
133 Parkinson disease 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
134 Parkinson disease 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
135 Parkinson disease 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
136 Parkinson disease 💬
1件: MAPT 💬 D11293 💬 Gosuranemab 1件:  5  💬
137 Pathways in cancer 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
138 Pathways in cancer 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
139 Pathways in cancer 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
140 Pathways of neurodegeneration - multiple diseases 💬
3件: CHRM1, CHRM3, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
141 Pathways of neurodegeneration - multiple diseases 💬
3件: CHRM1, CHRM3, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
142 Pathways of neurodegeneration - multiple diseases 💬
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
143 Pathways of neurodegeneration - multiple diseases 💬
1件: MAPT 💬 D11293 💬 Gosuranemab 1件:  5  💬
144 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
145 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
146 Phenylalanine metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
147 Phenylalanine metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
148 Phenylalanine metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
149 Phospholipase D signaling pathway 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
150 PI3K-Akt signaling pathway 💬
2件: CHRM1, CHRM2 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
151 PI3K-Akt signaling pathway 💬
2件: CHRM1, CHRM2 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
152 PI3K-Akt signaling pathway 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
153 Platelet activation 💬
1件: PTGS1 💬 D00428 💬 Salsalate 1件:  5  💬
154 Platelet activation 💬
1件: PTGS1 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
155 Prion disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
156 Propanoate metabolism 💬
1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
157 Rap1 signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
158 Rap1 signaling pathway 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
159 Ras signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
160 Ras signaling pathway 💬
1件: KIT 💬 D10229 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
161 Regulation of actin cytoskeleton 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
162 Regulation of actin cytoskeleton 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
163 Regulation of lipolysis in adipocytes 💬
3件: ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
164 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
165 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
166 Renin secretion 💬
3件: ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
167 Retrograde endocannabinoid signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
168 Retrograde endocannabinoid signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
169 Retrograde endocannabinoid signaling 💬
4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
170 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
171 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
172 Salivary secretion 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
173 Salivary secretion 💬
1件: CHRM3 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
174 Salivary secretion 💬
1件: CHRM3 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
175 Serotonergic synapse 💬
3件: GABRB1, GABRB2, GABRB3 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
176 Serotonergic synapse 💬
3件: GABRB1, GABRB2, GABRB3 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
177 Serotonergic synapse 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
178 Serotonergic synapse 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
179 Serotonergic synapse 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
180 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
181 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
182 Small cell lung cancer 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
183 Small cell lung cancer 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
184 Spinocerebellar ataxia 💬
8件: GRIA1, GRIA2, GRIA3, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
185 Synaptic vesicle cycle 💬
1件: SNAP25 💬 D00783 💬 Botulinum toxin type A 13件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
186 Systemic lupus erythematosus 💬
2件: GRIN2A, GRIN2B 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
187 Taste transduction 💬
1件: CHRM3 💬 D00787 💬 Trihexyphenidyl 2件:  5 ,  6  💬
188 Taste transduction 💬
1件: CHRM3 💬 D08638 💬 Trihexyphenidyl 2件:  5 ,  6  💬
189 Taste transduction 💬
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00706 💬 Zolpidem 3件:  5 ,  6 , 46 💬
190 Taste transduction 💬
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D08690 💬 Zolpidem 3件:  5 ,  6 , 46 💬
191 Taurine and hypotaurine metabolism 💬
2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
192 Thermogenesis 💬
1件: ADRB3 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
193 TNF signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
194 TNF signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬
195 Transcriptional misregulation in cancer 💬
1件: GRIA3 💬 D00775 💬 Riluzole 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
196 Tryptophan metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
197 Tryptophan metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
198 Tryptophan metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
199 Type I diabetes mellitus 💬
2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
200 Type II diabetes mellitus 💬
1件: CACNA1G 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
201 Tyrosine metabolism 💬
1件: MAOB 💬 D02562 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
202 Tyrosine metabolism 💬
1件: MAOB 💬 D08469 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
203 Tyrosine metabolism 💬
1件: MAOB 💬 D10829 💬 Rasagiline 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
204 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
205 Vascular smooth muscle contraction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D01277 💬 Droxidopa 3件:  5 ,  6 , 17 💬
206 VEGF signaling pathway 💬
1件: PTGS2 💬 D00428 💬 Salsalate 1件:  5  💬
207 VEGF signaling pathway 💬
1件: PTGS2 💬 D01183 💬 Tolfenamic acid 1件:  5  💬